FairJourney Biologics co-authors a Nature Medicine paper entitled: A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels. Nat Med. 2017 Aug 21. doi: 10.1038/nm.4390.
(https://www.ncbi.nlm.nih.gov/pubmed/28825717)